Valeant Pharmaceuticals International, Inc. (VRX,VRX.TO) announced its board has elected John Paulson to serve as a director, effective June 14, 2017. Paulson is the president of Paulson & Co., Inc., a New York-based investment firm.
Valeant noted that with the addition of Paulson, the company has a total of 11 members on its board, 10 of whom are independent.
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com
Business News